These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25483632)

  • 1. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
    Robbins HA; Waterboer T; Porras C; Kemp TJ; Pawlita M; Rodriguez AC; Wacholder S; Gonzalez P; Schiller JT; Lowy DR; Esser M; Matys K; Poncelet S; Herrero R; Hildesheim A; Pinto LA; Safaeian M
    Hum Vaccin Immunother; 2014; 10(10):2965-74. PubMed ID: 25483632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
    Robbins HA; Li Y; Porras C; Pawlita M; Ghosh A; Rodriguez AC; Schiffman M; Wacholder S; Kemp TJ; Gonzalez P; Schiller J; Lowy D; Esser M; Matys K; Quint W; van Doorn LJ; Herrero R; Pinto LA; Hildesheim A; Waterboer T; Safaeian M
    BMC Infect Dis; 2014 Mar; 14():120. PubMed ID: 24588945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antibody responses to human papillomavirus vaccination as measured by three assays.
    Robbins HA; Kemp TJ; Porras C; Rodriguez AC; Schiffman M; Wacholder S; Gonzalez P; Schiller J; Lowy D; Poncelet S; Esser M; Matys K; Hildesheim A; Pinto LA; Herrero R; Safaeian M
    Front Oncol; 2014 Jan; 3():328. PubMed ID: 24455487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial.
    Safaeian M; Porras C; Pan Y; Kreimer A; Schiller JT; Gonzalez P; Lowy DR; Wacholder S; Schiffman M; Rodriguez AC; Herrero R; Kemp T; Shelton G; Quint W; van Doorn LJ; Hildesheim A; Pinto LA;
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1242-50. PubMed ID: 24189371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination.
    Scherpenisse M; Schepp RM; Mollers M; Mooij SH; Meijer CJ; Berbers GA; van der Klis FR
    Clin Vaccine Immunol; 2013 Aug; 20(8):1329-32. PubMed ID: 23740920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial.
    Krajden M; Cook D; Yu A; Chow R; Su Q; Mei W; McNeil S; Money D; Dionne M; Palefsky J; Karunakaran K; Kollmann T; Ogilvie G; Petric M; Dobson S
    Vaccine; 2014 Jan; 32(5):624-30. PubMed ID: 24055350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.
    Kemp TJ; Matsui K; Shelton G; Safaeian M; Pinto LA
    Hum Vaccin Immunother; 2015; 11(2):337-46. PubMed ID: 25695397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial.
    Safaeian M; Kemp TJ; Pan DY; Porras C; Rodriguez AC; Schiffman M; Cortes B; Katki H; Wacholder S; Schiller JT; Gonzalez P; Penrose K; Lowy DR; Quint W; van Doorn LJ; Herrero R; Hildesheim A; Pinto LA
    Hum Vaccin Immunother; 2013 Jul; 9(7):1399-406. PubMed ID: 23571174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine.
    Pattyn J; Panicker G; Willhauck-Fleckenstein M; Van Keer S; Téblick L; Pieters Z; Tjalma WAA; Matheeussen V; Van Damme P; Waterboer T; Unger ER; Vorsters A
    J Med Virol; 2020 Dec; 92(12):3774-3783. PubMed ID: 32266996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
    Safaeian M; Porras C; Schiffman M; Rodriguez AC; Wacholder S; Gonzalez P; Quint W; van Doorn LJ; Sherman ME; Xhenseval V; Herrero R; Hildesheim A;
    J Natl Cancer Inst; 2010 Nov; 102(21):1653-62. PubMed ID: 20944077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines.
    Tsang SH; Basu P; Bender N; Herrero R; Kemp TJ; Kreimer AR; Müller M; Panicker G; Pawlita M; Pinto LA; Sampson JN; Sankaranarayanan R; Schussler J; Sehr P; Sierra MS; Unger ER; Waterboer T; Hildesheim A;
    Vaccine; 2020 Aug; 38(38):5997-6006. PubMed ID: 32713678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.
    Lin SW; Ghosh A; Porras C; Markt SC; Rodriguez AC; Schiffman M; Wacholder S; Kemp TJ; Pinto LA; Gonzalez P; Wentzensen N; Esser MT; Matys K; Meuree A; Quint W; van Doorn LJ; Herrero R; Hildesheim A; Safaeian M;
    PLoS One; 2013; 8(1):e53067. PubMed ID: 23301022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine.
    Dauner JG; Pan Y; Hildesheim A; Harro C; Pinto LA
    Vaccine; 2010 Jul; 28(33):5407-13. PubMed ID: 20591543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
    Coseo SE; Porras C; Dodd LE; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2011 Oct; 38(10):976-82. PubMed ID: 21934576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine.
    Godi A; Bissett SL; Miller E; Beddows S
    PLoS One; 2015; 10(10):e0140926. PubMed ID: 26495976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
    Gu Y; Wei M; Wang D; Li Z; Xie M; Pan H; Wu T; Zhang J; Li S; Xia N
    Vaccine; 2017 Aug; 35(35 Pt B):4637-4645. PubMed ID: 28736197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years.
    Schwarz TF; Huang LM; Valencia A; Panzer F; Chiu CH; Decreux A; Poncelet S; Karkada N; Folschweiller N; Lin L; Dubin G; Struyf F
    Hum Vaccin Immunother; 2019; 15(7-8):1970-1979. PubMed ID: 31268383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials.
    Safaeian M; Ghosh A; Porras C; Lin SW; Rodriguez AC; Schiffman M; Wacholder S; Kemp T; Gonzalez P; Wentzensen N; Esser M; Meuree A; Matys K; Quint W; van Doorn LJ; Sherman ME; Herrero R; Pinto LA; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1547-54. PubMed ID: 22752082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of bead-based immunoassay to quantify neutralizing antibody for human papillomavirus 16 and 18.
    Liu HB; Chaturvedi PK; Battogtokh G; Bang HJ; Kim IW; Kim YW; Park KS; Ahn WS
    Mol Biotechnol; 2013 Jun; 54(2):361-70. PubMed ID: 22669586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.